|
1
|
Sestak AL, Nath SK, Sawalha AH and Harley
JB: Current status of lupus genetics. Arthritis Res Ther.
9:2102007. View
Article : Google Scholar
|
|
2
|
Jönsen A, Bengtsson AA, Nived O, Truedsson
L and Sturfelt G: Gene-environment interactions in the aetiology of
systemic lupus erythematosus. Autoimmunity. 40:613–617.
2007.PubMed/NCBI
|
|
3
|
Attwood JT, Yung RL and Richardson BC: DNA
methylation and the regulation of gene transcription. Cell Mol Life
Sci. 59:241–257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Richardson BC: Role of DNA methylation in
the regulation of cell function: autoimmunity, aging and cancer. J
Nutr. 132(8 Suppl): 2401S–2405S. 2002.PubMed/NCBI
|
|
5
|
Richardson BC, Strahler JR, Pivirotto TS,
et al: Phenotypic and functional similarities between
5-azacytidine-treated T cells and a T cell subset in patients with
active systemic lupus erythematosus. Arthritis Rheum. 35:647–662.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yung R, Powers D, Johnson K, et al:
Mechanisms of drug-induced lupus. II. T cells overexpressing
lymphocyte function-associated antigen 1 become autoreactive and
cause a lupuslike disease in syngeneic mice. J Clin Invest.
97:2866–2871. 1996. View Article : Google Scholar
|
|
7
|
Quddus J, Johnson KJ, Gavalchin J, et al:
Treating activated CD4+ T cells with either of two
distinct DNA methyltransferase inhibitors, 5-azacytidine or
procainamide, is sufficient to cause a lupus-like disease in
syngeneic mice. J Clin Invest. 92:38–53. 1993.
|
|
8
|
Kaplan MJ, Lu Q, Wu A, Attwood J and
Richardson B: Demethylation of promoter regulatory elements
contributes to perforin overexpression in CD4+ lupus T
cells. J Immunol. 172:3652–3661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu Q, Ray D, Gutsch D and Richardson B:
Effect of DNA methylation and chromatin structure on ITGAL
expression. Blood. 99:4503–4508. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakao M: Epigenetics: interaction of DNA
methylation and chromatin. Gene. 278:25–31. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Richardson B and Yung R: Role of DNA
methylation in the regulation of cell function. J Lab Clin Med.
134:333–340. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Detich N, Theberge J and Szyf M:
Promoter-specific activation and demethylation by MBD2/demethylase.
J Biol Chem. 277:35791–35794. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan EM, Cohen AS, Fries JF, et al: The
1982 revised criteria for the classification of systemic lupus
erythematosus. Arthritis Rheum. 25:1271–1277. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wysenbeek AJ, Block DA and Fries JF:
Prevalence and expression of photosensitivity in systemic lupus
erythematosus. Ann Rheum Dis. 48:461–463. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lehmann P, Hölzle E, Kind P, Goerz G and
Plewig G: Experimental reproduction of skin lesions in lupus
erythematosus by UVA and UVB radiation. J Am Acad Dermatol.
22:181–187. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bombardier C, Gladman DD, Urowitz MB,
Caron D and Chang CH: Derivation of the SLEDAI. A disease activity
index for lupus patients The Committee on Prognosis Studies in SLE.
Arthritis Rheum. 35:630–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
WHO: Global Solar UV Index: A Practical
Guide. World Health Organization; Geneva, Switzerland: 2002
|
|
18
|
Gies P: Australia has more than enough
solar UV radiation. Clin Exp Optom. 86:71–73. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Habib M, Fares F, Bourgeois CA, et al: DNA
global hypomethylation in EBV-transformed interphase nuclei. Exp
Cell Res. 249:46–53. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Milutinovic S, Zhuang Q, Niveleau A and
Szyf M: Epigenomic stress response. Knockdown of DNA
methyltransferase 1 triggers an intra-S-phase arrest of DNA
replication and induction of stress response genes. J Biol Chem.
278:14985–14995. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X and Seed B: A PCR primer bank for
quantitative gene expression analysis. Nucleic Acids Res.
31:e1542003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fuke C, Shimabukuro M, Petronis A, et al:
Age related changes in 5-methylcytosine content in human peripheral
leukocytes and placentas: an HPLC-based study. Ann Hum Genet.
68:196–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klinman DM, Mushinski JF, Honda M, et al:
Oncogene expression in autoimmune and normal peripheral blood
mononuclear cells. J Exp Med. 163:1292–1307. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsokos GC and Kammer GM: Molecular
aberrations in human systemic lupus erythematosus. Mol Med Today.
6:418–424. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Surani MA: Imprinting and the initiation
of gene silencing in the germ line. Cell. 93:309–312. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ng HH and Bird A: DNA methylation and
chromatin modification. Curr Opin Genet Dev. 9:158–163. 1999.
View Article : Google Scholar
|
|
27
|
Knight SJ, Flannery AV, Hirst MC, et al:
Trinucleotide repeat amplification and hypermethylation of a CpG
island in FRAXE mental retardation. Cell. 74:127–134. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu GL, Bestor TH, Bourc’his D, et al:
Chromosome instability and immunodeficiency syndrome caused by
mutations in a DNA methyltransferase gene. Nature. 402:187–191.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yung R, Chang S, Hemati N, Johnson K and
Richardson B: Mechanisms of drug-induced lupus. IV. Comparison of
procainamide and hydralazine with analogs in vitro and in
vivo. Arthritis Rheum. 40:1436–1443. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yung RL, Quddus J, Chrisp CE, Johnson KJ
and Richardson BC: Mechanism of drug-induced lupus. I. Cloned Th2
cells modified with DNA methylation inhibitors in vitro
cause autoimmunity in vivo. J Immunol. 154:3025–3035.
1995.PubMed/NCBI
|
|
31
|
Sawalha AH and Richardson B: DNA
methylation in the pathogenesis of systemic lupus erythematosus.
Curr Pharmacogenomics. 3:73–78. 2005. View Article : Google Scholar
|
|
32
|
Deng C, Yang J, Scott J, Hanash S and
Richardson BC: Role of the ras-MAPK signaling pathway in the DNA
methyltransferase response to DNA hypomethylation. Biol Chem.
379:1113–1120. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Okano M, Xie S and Li E: Cloning and
characterization of a family of novel mammalian DNA (cytosine-5)
methyltransferases. Nat Genet. 19:219–220. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ogasawara H, Okada M, Kaneko H, Hishikawa
T, Sekigawa I and Hashimoto H: Possible role of DNA hypomethylation
in the induction of SLE: relationship to the transcription of human
endogenous retroviruses. Clin Exp Rheumatol. 21:733–738.
2003.PubMed/NCBI
|
|
35
|
Vertino PM, Yen RW, Gao J and Baylin SB:
De novo methylation of CpG island sequences in human
fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol
Cell Biol. 16:4555–4565. 1996.PubMed/NCBI
|
|
36
|
Fan G and Hutnick L: Methyl-CpG binding
proteins in the nervous system. Cell Res. 15:255–261. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Klose RJ and Bird AP: Genomic DNA
methylation: the mark and its mediators. Trends Biochem Sci.
31:89–97. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bhattacharya SK, Ramchandani S, Cervoni N
and Szyf M: A mammalian protein with specific demethylase activity
for mCpG DNA. Nature. 397:579–583. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ng HH, Zhang Y, Hendrich B, et al: MBD2 is
a transcriptional repressor belonging to the MeCP1 histone
deacetylase complex. Nat Genet. 23:58–61. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kastan MB, Gowans BJ and Lieberman MW:
Methylation of deoxycytidine incorporated by excision-repair
synthesis of DNA. Cell. 30:509–516. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lieberman MW, Beach LR and Palmiter RD:
Ultraviolet radiation-induced metallothionein-I gene activation is
associated with extensive DNA demethylation. Cell. 35:207–214.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang Z, Deng C, Lu Q and Richardson B:
Age-dependent DNA methylation changes in the ITGAL (CD11a)
promoter. Mech Ageing Dev. 123:1257–1268. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Balada E, Ordi-Ros J and Vilardell-Tarrés
M: DNA methylation and systemic lupus erythematosus. Ann NY Acad
Sci. 1108:127–136. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Richardson B, Scheinbart L, Strahler J,
Gross L, Hanash S and Johnson M: Evidence for impaired T cell DNA
methylation in systemic lupus erythematosus and rheumatoid
arthritis. Arthritis Rheum. 33:1665–1673. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nyce J, Liu L and Jones PA: Variable
effects of DNA-synthesis inhibitors upon DNA methylation in
mammalian cells. Nucleic Acids Res. 14:4353–4367. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Deng C, Kaplan MJ, Yang J, et al:
Decreased Ras-mitogen-activated protein kinase signaling may cause
DNA hypomethylation in T lymphocytes from lupus patients. Arthritis
Rheum. 44:397–407. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yoder JA, Soman NS, Verdine GL and Bestor
TH: DNA (cytosine-5)-methyltransferases in mouse cells and tissues.
Studies with a mechanism-based probe. J Mol Biol. 270:385–395.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lei W, Luo Y, Lei W, et al: Abnormal DNA
methylation in CD4+ T cells from patients with systemic
lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand
J Rheumatol. 38:369–374. 2009.PubMed/NCBI
|
